Ekihiro M Seki

Prof. Dr. Ekihiro M Seki


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 January 2019 in Seminars in Liver Disease
Verified
Journal Article
Closed access
PDF file
YYYoon Mee Yang
Yoon Mee Yang
SKSo Yeon Kim
So Yeon Kim
ESEkihiro M Seki
Ekihiro M Seki
Hepatocellular carcinoma (HCC) is associated with chronic inflammation and fibrosis arising from different etiologies, including hepatitis B and C and alcoholic and nonalcoholic fatty liver diseases. The inflammatory cytokines tumor necrosis factor-α and interleukin-6 and their downstream targets nuclear factor kappa B (NF-κB), c-Jun N-terminal kinase (JNK), and signal transducer and activator of transcription 3 drive inflammation-associated HCC. Further, while adaptive immunity promotes immune surveillance to eradicate early HCC, adaptive immune cells, such as CD8+ T cells, Th17 cells, and B cells, can also stimulate HCC development. Thus, the role of the hepatic immune system in HCC development is a highly complex topic. This review highlights the role of cytokine signals, NF-κB, JNK, innate and adaptive immunity, and hepatic stellate cells in HCC and discusses whether these pathways could be therapeutic targets. The authors will also discuss cholangiocarcinoma and liver metastasis because biliary inflammation and tumor-associated stroma are essential for cholangiocarcinoma development and because primary tumor-derived inflammatory mediators promote the formation of a “premetastasis niche” in the liver.

1 June 2021 in Journal of Clinical Investigation
Verified
Journal Article
Closed access
PDF file
SBSonakshi Bhattacharjee
Sonakshi Bhattacharjee
FHFlorian Hamberger
Florian Hamberger
ARAashreya Ravichandra
Aashreya Ravichandra
MMMaximilian Miller
Maximilian Miller
ANAjay Nair
Ajay Nair
RSRobert F. Schwabe
Robert F. Schwabe
Cancer-associated fibroblasts (CAF) may exert tumor-promoting and tumor-suppressive functions, but the mechanisms underlying these opposing effects remain elusive. Here, we sought to understand these potentially opposing functions by interrogating functional relationships among CAF subtypes, their mediators, desmoplasia, and tumor growth in a wide range of tumor types metastasizing to the liver, the most common organ site for metastasis. Depletion of hepatic stellate cells (HSC), which represented the main source of CAF in mice and patients in our study, or depletion of all CAF decreased tumor growth and mortality in desmoplastic colorectal and pancreatic metastasis but not in nondesmoplastic metastatic tumors. Single-cell RNA-Seq in conjunction with CellPhoneDB ligand-receptor analysis, as well as studies in immune cell–depleted and HSC-selective knockout mice, uncovered direct CAF-tumor interactions as a tumor-promoting mechanism, mediated by myofibroblastic CAF–secreted (myCAF-secreted) hyaluronan and inflammatory CAF–secreted (iCAF-secreted) HGF. These effects were opposed by myCAF-expressed type I collagen, which suppressed tumor growth by mechanically restraining tumor spread, overriding its own stiffness-induced mechanosignals. In summary, mechanical restriction by type I collagen opposes the overall tumor-promoting effects of CAF, thus providing a mechanistic explanation for their dual functions in cancer. Therapeutic targeting of tumor-promoting CAF mediators while preserving type I collagen may convert CAF from tumor promoting to tumor restricting.

1 June 2021 in Cancer Cell
Verified
Journal Article
Closed access
SASilvia Affo
Silvia Affo
ANAjay Nair
Ajay Nair
FBFrancesco Brundu
Francesco Brundu
ARAashreya Ravichandra
Aashreya Ravichandra
SBSonakshi Bhattacharjee
Sonakshi Bhattacharjee
RSRobert F. Schwabe
Robert F. Schwabe

13 April 2015 in Journal of Hepato-Biliary-Pancreatic Sciences
Verified
Journal Article
Closed access
PDF file
ESEkihiro M Seki
Ekihiro M Seki
DBDavid Allen Brenner
David Allen Brenner

2 April 2020 in Seminars in Liver Disease
Verified
Journal Article
Closed access
PDF file
MMMichitaka Matsuda
Michitaka Matsuda
ESEkihiro M Seki
Ekihiro M Seki
Chronic liver injury due to viral hepatitis, alcohol abuse, and metabolic disorders is a worldwide health concern. Insufficient treatment of chronic liver injury leads to fibrosis, causing liver dysfunction and carcinogenesis. Most cases of hepatocellular carcinoma (HCC) develop in the fibrotic liver. Pathological features of liver fibrosis include extracellular matrix (ECM) accumulation, mesenchymal cell activation, immune deregulation, and angiogenesis, all of which contribute to the precancerous environment, supporting tumor development. Among liver cells, hepatic stellate cells (HSCs) and macrophages play critical roles in fibrosis and HCC. These two cell types interplay and remodel the ECM and immune microenvironment in the fibrotic liver. Once HCC develops, HCC-derived factors influence HSCs and macrophages to switch to protumorigenic cell populations, cancer-associated fibroblasts and tumor-associated macrophages, respectively. This review aims to summarize currently available data on the roles of HSCs and macrophages in liver fibrosis and HCC, with a focus on their interaction.

30 September 2015 in Current Pathobiology Reports
Verified
Journal Article
Closed access
PDF file
YYYoon Mee Yang
Yoon Mee Yang
ESEkihiro M Seki
Ekihiro M Seki